Director, Business Excellence Portfolio Strategy

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

The Business Excellence Strategy group within Global Portfolio Strategy & Operations works side-by-side with the Aesthetics R&D executive team on many of the most pressing issues facing the organization, both in the short term and long term. Work from this team will have a direct impact on the future success of AbbVie.

As a Director of Business Excellence Strategy, you will partner with leaders across AbbVie to optimize the value of our early discovery pipeline and current/future assets. The role is seeking a high performing team member who has demonstrated an interest and expertise in the biopharma industry and strong desire to advance our strategic agenda and support mission-critical discovery strategies + initiatives that will make a real difference for AbbVie’s patients. In return the Business Excellence group will provide high profile, high impact projects and professional development experiences spanning the entire drug development value chain.

The position requires strong analytical skills, the ability to translate strategic vision into tactical action, identify the highest impact ideas and plans and focus efforts to work well in a cross-functional team.

This role will be based onsite in Irvine, CA.

Responsibilities:

• Partner with the Biological Research Leadership Team to advance strategic initiatives and programs related to Early Research (incl. capability builds, capital expansion, early research strategy)
• Dedicated strategy and executive communication support for Early Research as we move critical research activities through early research governance and executive reviews prior to late discovery research transition
• Supports additi